Marc-Alexander Mahl

Marc Mahl brings a comprehensive portfolio to the Management Board with extensive experience in the pharmaceutical and nutrition industry. His focus is on strategy, development, production, M&A, and reorganization management. Before his current position, he served as Head of Business Unit Generics and IV Fluids EU & RoW of Fresenius Kabi. Marc is a trained physician, specializing in transfusion medicine and holds an eMBA degree from INSEAD.